featured
Empagliflozin Improves HF Outcomes Across All EF Subgroups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
Eur Heart J 2021 Dec 08;[EPub Ahead of Print], J Butler, M Packer, G Filippatos, JP Ferreira, C Zeller, J Schnee, M Brueckmann, SJ Pocock, F Zannad, SD AnkerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.